nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PLA2G4A—Orlistat—type 2 diabetes mellitus	0.201	0.316	CbGbCtD
Niflumic Acid—PTGS2—type 2 diabetes mellitus	0.185	1	CbGaD
Niflumic Acid—SLC16A1—Nateglinide—type 2 diabetes mellitus	0.147	0.231	CbGbCtD
Niflumic Acid—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0845	0.133	CbGbCtD
Niflumic Acid—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0463	0.0727	CbGbCtD
Niflumic Acid—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0463	0.0727	CbGbCtD
Niflumic Acid—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0427	0.0671	CbGbCtD
Niflumic Acid—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0351	0.0551	CbGbCtD
Niflumic Acid—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0336	0.0529	CbGbCtD
Niflumic Acid—CLCNKA—nephron tubule—type 2 diabetes mellitus	0.00526	0.102	CbGeAlD
Niflumic Acid—CLCNKA—kidney—type 2 diabetes mellitus	0.00462	0.0899	CbGeAlD
Niflumic Acid—CLCNKA—liver—type 2 diabetes mellitus	0.00292	0.0568	CbGeAlD
Niflumic Acid—PLA2G1B—islet of Langerhans—type 2 diabetes mellitus	0.00258	0.0502	CbGeAlD
Niflumic Acid—PTGS2—leg—type 2 diabetes mellitus	0.00226	0.0439	CbGeAlD
Niflumic Acid—PTGS2—hindlimb—type 2 diabetes mellitus	0.00201	0.0392	CbGeAlD
Niflumic Acid—PLA2G1B—cardiovascular system—type 2 diabetes mellitus	0.00187	0.0363	CbGeAlD
Niflumic Acid—PLA2G1B—kidney—type 2 diabetes mellitus	0.00183	0.0355	CbGeAlD
Niflumic Acid—PLA2G1B—pancreas—type 2 diabetes mellitus	0.00181	0.0353	CbGeAlD
Niflumic Acid—SLC16A7—nephron tubule—type 2 diabetes mellitus	0.00175	0.0341	CbGeAlD
Niflumic Acid—UGT1A9—kidney—type 2 diabetes mellitus	0.00167	0.0325	CbGeAlD
Niflumic Acid—SLC16A7—cardiovascular system—type 2 diabetes mellitus	0.00157	0.0306	CbGeAlD
Niflumic Acid—SLC16A7—cortex of kidney—type 2 diabetes mellitus	0.0015	0.0291	CbGeAlD
Niflumic Acid—SLC16A7—adipose tissue—type 2 diabetes mellitus	0.00139	0.027	CbGeAlD
Niflumic Acid—PTGS1—artery—type 2 diabetes mellitus	0.00129	0.0251	CbGeAlD
Niflumic Acid—Leflunomide—CYP1A2—type 2 diabetes mellitus	0.00125	0.576	CrCbGaD
Niflumic Acid—PTGS2—artery—type 2 diabetes mellitus	0.00123	0.024	CbGeAlD
Niflumic Acid—SLC16A1—retina—type 2 diabetes mellitus	0.00118	0.023	CbGeAlD
Niflumic Acid—PLA2G4A—cardiovascular system—type 2 diabetes mellitus	0.00114	0.0221	CbGeAlD
Niflumic Acid—PTGS1—endothelium—type 2 diabetes mellitus	0.00109	0.0212	CbGeAlD
Niflumic Acid—PLA2G4A—cortex of kidney—type 2 diabetes mellitus	0.00108	0.0211	CbGeAlD
Niflumic Acid—UGT1A9—liver—type 2 diabetes mellitus	0.00106	0.0205	CbGeAlD
Niflumic Acid—PTGS2—endothelium—type 2 diabetes mellitus	0.00104	0.0203	CbGeAlD
Niflumic Acid—PLA2G4A—adipose tissue—type 2 diabetes mellitus	0.001	0.0195	CbGeAlD
Niflumic Acid—SLC16A1—cardiovascular system—type 2 diabetes mellitus	0.001	0.0195	CbGeAlD
Niflumic Acid—SLC16A1—kidney—type 2 diabetes mellitus	0.000979	0.0191	CbGeAlD
Niflumic Acid—SLC16A7—liver—type 2 diabetes mellitus	0.000972	0.0189	CbGeAlD
Niflumic Acid—SLC16A1—adipose tissue—type 2 diabetes mellitus	0.000882	0.0172	CbGeAlD
Niflumic Acid—PLA2G4A—Glyburide—Tolazamide—type 2 diabetes mellitus	0.000725	0.17	CbGdCrCtD
Niflumic Acid—PLA2G4A—Glyburide—Glimepiride—type 2 diabetes mellitus	0.000725	0.17	CbGdCrCtD
Niflumic Acid—PLA2G4A—Glyburide—Gliclazide—type 2 diabetes mellitus	0.000688	0.161	CbGdCrCtD
Niflumic Acid—PLA2G4A—Glyburide—Glipizide—type 2 diabetes mellitus	0.000688	0.161	CbGdCrCtD
Niflumic Acid—Floctafenine—PTGS2—type 2 diabetes mellitus	0.00066	0.305	CrCbGaD
Niflumic Acid—PLA2G4A—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.000629	0.148	CbGdCrCtD
Niflumic Acid—SLC16A1—liver—type 2 diabetes mellitus	0.000619	0.012	CbGeAlD
Niflumic Acid—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000593	0.0115	CbGeAlD
Niflumic Acid—PLA2G4A—Enalapril—Nateglinide—type 2 diabetes mellitus	0.000502	0.118	CbGdCrCtD
Niflumic Acid—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000449	0.00873	CbGeAlD
Niflumic Acid—PTGS1—kidney—type 2 diabetes mellitus	0.000439	0.00855	CbGeAlD
Niflumic Acid—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000429	0.00835	CbGeAlD
Niflumic Acid—PTGS2—kidney—type 2 diabetes mellitus	0.00042	0.00817	CbGeAlD
Niflumic Acid—PTGS2—pancreas—type 2 diabetes mellitus	0.000417	0.00811	CbGeAlD
Niflumic Acid—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000396	0.0077	CbGeAlD
Niflumic Acid—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000378	0.00736	CbGeAlD
Niflumic Acid—PLA2G4A—Enalapril—Ramipril—type 2 diabetes mellitus	0.000305	0.0716	CbGdCrCtD
Niflumic Acid—PTGS2—liver—type 2 diabetes mellitus	0.000265	0.00516	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS2—type 2 diabetes mellitus	0.000258	0.119	CrCbGaD
Niflumic Acid—PLA2G4A—Metabolism—HMOX1—type 2 diabetes mellitus	1.26e-05	0.000104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.25e-05	0.000103	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CALM1—type 2 diabetes mellitus	1.25e-05	0.000103	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.25e-05	0.000103	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CAT—type 2 diabetes mellitus	1.24e-05	0.000103	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOE—type 2 diabetes mellitus	1.24e-05	0.000103	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTR—type 2 diabetes mellitus	1.24e-05	0.000103	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.24e-05	0.000102	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.23e-05	0.000102	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	1.23e-05	0.000102	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.23e-05	0.000102	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.23e-05	0.000102	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOA1—type 2 diabetes mellitus	1.23e-05	0.000102	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.23e-05	0.000101	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	1.22e-05	0.000101	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GCG—type 2 diabetes mellitus	1.22e-05	0.000101	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.22e-05	0.000101	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	1.22e-05	0.000101	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GCK—type 2 diabetes mellitus	1.21e-05	0.0001	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.21e-05	9.99e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOB—type 2 diabetes mellitus	1.21e-05	9.98e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.21e-05	9.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IAPP—type 2 diabetes mellitus	1.2e-05	9.94e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.19e-05	9.82e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—type 2 diabetes mellitus	1.18e-05	9.76e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.18e-05	9.76e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—type 2 diabetes mellitus	1.18e-05	9.71e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.16e-05	9.62e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—LPL—type 2 diabetes mellitus	1.15e-05	9.53e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.15e-05	9.51e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.15e-05	9.5e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.15e-05	9.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	1.15e-05	9.46e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	1.15e-05	9.46e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	1.15e-05	9.46e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.14e-05	9.39e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.13e-05	9.34e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ADCY5—type 2 diabetes mellitus	1.13e-05	9.33e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GPX1—type 2 diabetes mellitus	1.13e-05	9.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	1.12e-05	9.29e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.11e-05	9.2e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.11e-05	9.14e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.1e-05	9.08e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CD36—type 2 diabetes mellitus	1.1e-05	9.05e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.09e-05	9.01e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.09e-05	8.97e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.09e-05	8.97e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPARG—type 2 diabetes mellitus	1.08e-05	8.95e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPP2CA—type 2 diabetes mellitus	1.08e-05	8.94e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.07e-05	8.83e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—INS—type 2 diabetes mellitus	1.06e-05	8.77e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.06e-05	8.77e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.06e-05	8.75e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—AKT1—type 2 diabetes mellitus	1.06e-05	8.72e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.05e-05	8.69e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.05e-05	8.67e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GNB3—type 2 diabetes mellitus	1.05e-05	8.67e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.05e-05	8.65e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.05e-05	8.63e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.05e-05	8.63e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—HMOX1—type 2 diabetes mellitus	1.05e-05	8.63e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.04e-05	8.6e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.04e-05	8.59e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.04e-05	8.59e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—type 2 diabetes mellitus	1.04e-05	8.58e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.04e-05	8.56e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.04e-05	8.56e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.04e-05	8.56e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CAT—type 2 diabetes mellitus	1.03e-05	8.52e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.03e-05	8.47e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.02e-05	8.43e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARA—type 2 diabetes mellitus	1.02e-05	8.42e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.02e-05	8.4e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.01e-05	8.38e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.01e-05	8.37e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.01e-05	8.37e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.01e-05	8.37e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.01e-05	8.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.01e-05	8.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.01e-05	8.32e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.01e-05	8.31e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1e-05	8.3e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOB—type 2 diabetes mellitus	1e-05	8.27e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.94e-06	8.21e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.93e-06	8.2e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	9.93e-06	8.2e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	9.89e-06	8.17e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AGT—type 2 diabetes mellitus	9.87e-06	8.15e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	9.82e-06	8.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	9.78e-06	8.08e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—type 2 diabetes mellitus	9.74e-06	8.04e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ALB—type 2 diabetes mellitus	9.74e-06	8.04e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CALM1—type 2 diabetes mellitus	9.7e-06	8.02e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS1—type 2 diabetes mellitus	9.68e-06	7.99e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOE—type 2 diabetes mellitus	9.67e-06	7.99e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LPL—type 2 diabetes mellitus	9.65e-06	7.97e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	9.6e-06	7.93e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	9.57e-06	7.91e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—LPL—type 2 diabetes mellitus	9.56e-06	7.9e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOA1—type 2 diabetes mellitus	9.56e-06	7.9e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.44e-06	7.8e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	9.41e-06	7.78e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ADCY5—type 2 diabetes mellitus	9.36e-06	7.73e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPX1—type 2 diabetes mellitus	9.33e-06	7.7e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.32e-06	7.69e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—NOS3—type 2 diabetes mellitus	9.32e-06	7.69e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.12e-06	7.53e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	9.09e-06	7.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	9.09e-06	7.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	9.09e-06	7.51e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CD36—type 2 diabetes mellitus	9.08e-06	7.5e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.05e-06	7.48e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPP2CA—type 2 diabetes mellitus	8.97e-06	7.41e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	8.92e-06	7.37e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.89e-06	7.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	8.84e-06	7.31e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	8.72e-06	7.21e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—C3—type 2 diabetes mellitus	8.69e-06	7.17e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	8.66e-06	7.15e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—type 2 diabetes mellitus	8.61e-06	7.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	8.56e-06	7.07e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.56e-06	7.07e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	8.52e-06	7.04e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—type 2 diabetes mellitus	8.52e-06	7.04e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARA—type 2 diabetes mellitus	8.44e-06	6.97e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARG—type 2 diabetes mellitus	8.42e-06	6.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	8.41e-06	6.94e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	8.32e-06	6.87e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.28e-06	6.84e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.26e-06	6.83e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—INS—type 2 diabetes mellitus	8.26e-06	6.82e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AGT—type 2 diabetes mellitus	8.25e-06	6.82e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	8.22e-06	6.79e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	8.22e-06	6.79e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—AKT1—type 2 diabetes mellitus	8.21e-06	6.78e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	8.19e-06	6.76e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AGT—type 2 diabetes mellitus	8.18e-06	6.76e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	8.16e-06	6.74e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.11e-06	6.7e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOE—type 2 diabetes mellitus	8.09e-06	6.68e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—type 2 diabetes mellitus	8.09e-06	6.68e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CALM1—type 2 diabetes mellitus	8.04e-06	6.64e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	8.02e-06	6.62e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOE—type 2 diabetes mellitus	8.01e-06	6.62e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.99e-06	6.6e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	7.94e-06	6.56e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	7.93e-06	6.55e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOA1—type 2 diabetes mellitus	7.92e-06	6.54e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	7.88e-06	6.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	7.88e-06	6.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	7.79e-06	6.44e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOB—type 2 diabetes mellitus	7.74e-06	6.39e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	7.63e-06	6.3e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.63e-06	6.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	7.6e-06	6.28e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ALB—type 2 diabetes mellitus	7.57e-06	6.26e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	7.4e-06	6.12e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LPL—type 2 diabetes mellitus	7.39e-06	6.1e-05	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKT1—type 2 diabetes mellitus	7.32e-06	6.05e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.31e-06	6.04e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3R1—type 2 diabetes mellitus	7.24e-06	5.98e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—NOS3—type 2 diabetes mellitus	7.24e-06	5.98e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	7.23e-06	5.97e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.21e-06	5.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	7.02e-06	5.8e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARG—type 2 diabetes mellitus	6.98e-06	5.77e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	6.93e-06	5.72e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—INS—type 2 diabetes mellitus	6.91e-06	5.71e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	6.88e-06	5.69e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—INS—type 2 diabetes mellitus	6.85e-06	5.65e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CCR5—type 2 diabetes mellitus	6.81e-06	5.62e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.8e-06	5.61e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	6.79e-06	5.61e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.79e-06	5.61e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	6.76e-06	5.59e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.68e-06	5.52e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.68e-06	5.52e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	6.67e-06	5.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	6.67e-06	5.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	6.65e-06	5.49e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.65e-06	5.49e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—type 2 diabetes mellitus	6.63e-06	5.47e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	6.55e-06	5.41e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	6.53e-06	5.4e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	6.48e-06	5.35e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	6.46e-06	5.33e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.34e-06	5.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	6.34e-06	5.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IRS2—type 2 diabetes mellitus	6.33e-06	5.23e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	6.3e-06	5.21e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	6.28e-06	5.18e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CALM1—type 2 diabetes mellitus	6.21e-06	5.13e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOE—type 2 diabetes mellitus	6.19e-06	5.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	6.19e-06	5.11e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOA1—type 2 diabetes mellitus	6.12e-06	5.06e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.06e-06	5e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.06e-06	5e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	6.06e-06	5e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	6.04e-06	4.99e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	6e-06	4.96e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	6e-06	4.96e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	5.88e-06	4.86e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.8e-06	4.79e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS2—type 2 diabetes mellitus	5.77e-06	4.77e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.7e-06	4.71e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.69e-06	4.7e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—INS—type 2 diabetes mellitus	5.58e-06	4.61e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	5.57e-06	4.6e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IRS1—type 2 diabetes mellitus	5.52e-06	4.56e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	5.49e-06	4.54e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	5.46e-06	4.51e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	5.29e-06	4.37e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—INS—type 2 diabetes mellitus	5.29e-06	4.37e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	5.2e-06	4.3e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	5.19e-06	4.28e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.14e-06	4.25e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	5.13e-06	4.23e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	5.12e-06	4.23e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT2—type 2 diabetes mellitus	5.11e-06	4.22e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.11e-06	4.22e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	4.89e-06	4.04e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.89e-06	4.04e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.86e-06	4.01e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	4.86e-06	4.01e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.81e-06	3.97e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.71e-06	3.89e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.64e-06	3.83e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.64e-06	3.83e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	4.52e-06	3.73e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.48e-06	3.7e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.48e-06	3.7e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.43e-06	3.66e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.36e-06	3.6e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKT1—type 2 diabetes mellitus	4.28e-06	3.54e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	4.06e-06	3.35e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.01e-06	3.31e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.93e-06	3.24e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.88e-06	3.21e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	3.88e-06	3.21e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.43e-06	2.83e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKT1—type 2 diabetes mellitus	3.33e-06	2.75e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	3.07e-06	2.53e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.02e-06	2.49e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGFR—type 2 diabetes mellitus	3.01e-06	2.48e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.78e-06	2.3e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	2.76e-06	2.28e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.31e-06	1.91e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.25e-06	1.86e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.13e-06	1.76e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.79e-06	1.48e-05	CbGpPWpGaD
